Evidence mapPaperPMID 40022609Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Insulin receptor responsiveness governs TGFβ-induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis.

Wang-Hsin Lee, Evelyn A Bates, Zachary A Kipp, Sally N Pauss, Genesee J Martinez, Cheavar A Blair, Terry D Hinds

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Integrative Multi-Omics Analysis Elucidates the Progressive Disease Landscape and Reveals Dynamic Protein Biomarkers for MASLD Surveillance.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Metabolites · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wang-Hsin LeeDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0001-5258-8318
Evelyn A BatesDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0002-4157-2481
Zachary A KippDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0001-7344-7469
Sally N PaussDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0002-7365-7172
Genesee J MartinezDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0002-4593-7708
Cheavar A BlairDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0002-0289-439X
Terry D HindsDrug & Disease Discovery D3 Research Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0002-7599-1529

Funding

Neurobehavioral mechanisms underlying xylazine and fentanyl co-use and withdrawalR01DA058933 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$497k
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic DysfunctionF31HL170972 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$36k
PPARgamma Coregulators in Rosiglitazone-Induced Cardiovascular DiseaseF31HL175979 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$35k
American Heart Association (AHA) 25PRE1374495HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) F31HL170972HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) F31HL175979HHS | NIH | National Institute on Drug Abuse (NIDA) R01DA058933HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) R01DK121797NHLBI NIH HHS F31 HL170972NHLBI NIH HHS F31 HL175979NIDA NIH HHS R01 DA058933NIDDK NIH HHS R01 DK121797
6 · The paper itself

Abstract

The insulin receptor (INSR) has been shown to be hyperactive in hepatic stellate cells (HSCs) in humans and rodents with liver fibrosis. To explore HSC cellular mechanisms that INSR regulates during pro-fibrotic stimulation, we used CRISPR-Cas9 technology. We knocked out a portion of the INSR gene in human LX2 HSC cells (INSR

Indexed as

Hepatic Stellate CellsInsulin ResistanceLiver CirrhosisReceptor, InsulinCell LineCell MovementCell ProliferationCRISPR-Cas SystemsGene Regulatory NetworksHumansSignal TransductionTransforming Growth Factor betaReceptor, InsulinTransforming Growth Factor betacirrhosisdiabetesfatty livergrowthkinomeMASHMASLDPamGeneproliferation

Identifiers

PMID40022609
PMCPMC11871568

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.